Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
4 A 52-year-old male patient began exhibiting symptoms three weeks after receiving the fourth dose of BGM0504
Jenkins, R
In addition to its glucose-lowering and weight-loss effects, tirzepatide is currently undergoing Phase 3 or 4 clinical trials for other conditions, including obesity with osteoarthritis, atherosclerosis in T2DM patients, lipid metabolism and brain function in T2DM patients, and obstructive sleep apnea
Fake FDA registration: In the comment section of the ad, the page attached a supposedly FDA registration for the product
US$ 29.75
US$ 22.08
US$ 21.99
US$ 26.09
US$ 26.77
US$ 23.83
US$ 27.42
